1. Rheumatol Adv Pract. 2022 May 9;6(2):rkac035. doi: 10.1093/rap/rkac035. 
eCollection 2022.

An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 
gene mutations successfully treated with tocilizumab.

Lee J(1), Bizzocchi L(2), Jain R(1), Tagoe CE(1).

Author information:
(1)Department of Medicine, Albert Einstein College of Medicine, Montefiore 
Medical Center, Bronx, NY.
(2)Department of Rheumatology, CoxHealth, Springfield, MO, USA.

DOI: 10.1093/rap/rkac035
PMCID: PMC9113507
PMID: 35591901